Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Scientists found a specific group of itch-sensing nerve cells in mice important for feeling itch but not for sensing heat or touch.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher IL-17A levels indicate more severe alopecia areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

TNF-alpha inhibitors can cause various immune-related skin issues.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

IL-6 from stem cells helps repair skin and grow hair.